🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Express Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could result in individuals injecting products of uncertain source.

Some professionals said the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Reaction and Material Removal

Based on the social media company, the service has taken down problematic material and banned related hashtags and query recommendations. The company said it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered groups with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of entering one community, a vendor shared contact information, where most transactions occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or past usage.

Item Information and Costs

Within these groups, messages display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how long a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram said it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Even if the science behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has already encountered individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious medical dangers”.